Frequently Asked Questions What is the main difference between CJC-1295 no DAC & Ipamorelin and MK-677
This product serves research purposes only and does not act as a medical treatment
Use our peptide cost calculator to compare pricing across vial sizes for your specific protocol
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Refrain from taking antihistamines 24 hours before the procedure
The GLP-1 injection site guide covers optimal locations and rotation strategies
